Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.14395
Abstract: The management of small cell lung cancer (SCLC) has reached a plateau. Etoposide and platinum-based chemotherapy plus thoracic irradiation remain the standard treatment strategy for SCLC. Our study aims to assess the potential prognostic factors… read more here.
Keywords: chemotherapy; irradiation; platinum based; analysis ... See more keywords
Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13040643
Abstract: Simple Summary Grade 3 neuroendocrine neoplasms (G3 NEN) are a heterogenous subtype of NEN, including well-differentiated neuroendocrine tumors (G3 NET) and poorly differentiated large- or small-cell type carcinomas (NEC). Until recently, all G3 NEN were… read more here.
Keywords: chemotherapy; response; biomarkers response; neuroendocrine neoplasms ... See more keywords